Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksINTEGFD
statements
INTEGFD

Integrated Proteins Ltd.

BSE: 519606
Industry: Edible Oil
130.00-1.0 (-0.76%)
26 Aug, 12:00 AM

Income Statement

Abridged
Understanding Income Statement
Integrated Proteins Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
TTM
Jun 30
Period length:
Source:
12M
AR
12M
AR
12M
AR
12M
PRESS
12M
IR
Total Revenue
0.170.2421.509.9420.44
Cost of Operating Revenue
0.180.2521.039.5019.48
Gross Profit
-0.01-0.010.460.430.95
Gross Margin
-5.2-4.82.14.44.7
Total Operating Expenses
0.280.3821.419.6619.67
Operating Profit
-0.11-0.150.080.280.77
Operating Margin
-68.3-61.10.42.83.8
Financing Income/(Expense) - Net
0.160.160.15--
Profit before Taxes
0.040.100.320.280.77
Income Taxes
0.010.010.070.060.18
Profit after Tax
0.030.090.250.230.59
PAT Margin
18.537.61.22.32.9
EPS - Basic - ex Extraordinary Items
0.100.280.710.120.40
EPS - Diluted - ex Extraordinary Items
0.100.280.710.120.40
EBIT
-0.11-0.150.080.280.77
EBITDA
-0.09-0.120.090.280.77
EBITDA Margin
-51.1-50.00.42.83.8

Balance Sheet

Abridged
Understanding Balance Sheet
Integrated Proteins Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Source:
AR
AR
AR
PRESS
Total Current Assets
0.070.1032.3220.56
Long-Term Investments
0.100.150.000.00
Property Plant & Equipment - Net
0.410.420.050.05
Total Non-Current Assets
2.752.640.050.05
Total Assets
2.812.7432.3720.61
Total Current Liabilities
0.080.0812.250.08
Long Term Debt
0.190.03--
Total Non-Current Liabilities
0.210.050.000.00
Total Liabilities
0.290.1312.250.08
Total Shareholders' Equity
2.522.6120.1220.53
Total Equity
2.522.6120.1220.53
Total Liabilities & Equity
2.812.7432.3720.61

Cash Flow

Abridged
Understanding Cash Flow Statement
Integrated Proteins Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
AR
12M
AR
12M
AR
12M
PRESS
Operating CF bef Changes in Working Cap
0.050.110.180.22
Working Capital - Increase/(Decrease)
-0.02-0.02-23.593.38
Net CF from Operating Activities
0.040.09-23.413.60
Capital Expenditures - Net
--0.04-0.43-
Net CF from Investing Activities
-0.160.002.32-
Stock - Issuance/(Retirement) - Net
--17.260.19
Debt - LT & ST - Issuance/(Retirement) - Total
0.11-0.163.86-3.90
Net Cash Flow from Financing Activities
0.11-0.1621.12-3.71
Free Cash Flow to Equity
0.15-0.02-19.13-0.29
Free Operating CF net dividend
0.040.09-23.41-
Free Operating CF
0.040.09-23.41-

Business Segment Analysis

Integrated Proteins Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Integrated Proteins Ltd.

Regional Segment Analysis

Integrated Proteins Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Integrated Proteins Ltd.

Historical Segment Analysis

Track how Integrated Proteins Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Integrated Proteins Ltd.

Frequently Asked Questions

What is the revenue of Integrated Proteins Ltd.?
The latest trailing twelve month revenue of Integrated Proteins Ltd. is ₹ 20.44 Cr, reflecting a 1-year growth of -4.93% and a 3-year CAGR of 396.57%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Integrated Proteins Ltd.?
The latest trailing twelve month net profit (PAT) of Integrated Proteins Ltd. is ₹ 0.59 Cr, with a 3-year earnings CAGR of 100.00%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Integrated Proteins Ltd.?
The trailing twelve month EBITDA of Integrated Proteins Ltd. is approximately ₹ 0.77 Cr (based on an operating margin of 3.75%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Integrated Proteins Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Integrated Proteins Ltd. is 0.40. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Integrated Proteins Ltd.?
The debt-to-equity ratio of Integrated Proteins Ltd. stands at 0.00. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Integrated Proteins Ltd.?
The estimated book value per share of Integrated Proteins Ltd. is 64.07 (derived from a P/B ratio of 2.03 and market price of ₹ 130.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Integrated Proteins Ltd.?
The trailing twelve month operating cash flow of Integrated Proteins Ltd. is ₹ 3.60 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Integrated Proteins Ltd. report consolidated or standalone financials?
Integrated Proteins Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.